Status:
UNKNOWN
Integration of Minimal Invasive Cardiopulmonary Bypass System and the Research of Its Blood Compatibility
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Cardiopulmonary Bypass
Cardiac Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Research objective: (1) To develop a minimally invasive extracorporeal circulation integrated system, and to form a new product package, the package of the system should include the extracorporeal ci...
Detailed Description
Research objective: (1) To develop a minimally invasive extracorporeal circulation integrated system, and to form a new product package, the package of the system should include the extracorporeal ci...
Eligibility Criteria
Inclusion
- Patient weight ≤60kg;
- Age ≥18 years old;
- The patient underwent cardiac arrest surgery.
Exclusion
- Heart transplant patients;
- Emergency cardiac surgery patients;
- Patients who had been assisted by extracorporeal membrane oxygenator (ECMO) or assisted by left heart before operation
- Left ventricular ejection fraction (LVEF) \< 30%;
- Patients with coagulation dysfunction before surgery;
- Patients with preoperative hepatic and renal insufficiency;
- Recent cerebrovascular accident patients.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04476342
Start Date
June 1 2019
End Date
December 31 2021
Last Update
July 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310009